Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04563078 · ClinicalTrials.gov registry record · NA
Effect of TMS on PTSD Biomarkers
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT04563078 is a NA study that has completed, run by Emory University. The registered enrollment target is 50 participants.
The verdict
NCT04563078, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The study will (1) assess feasibility of a TMS treatment in an underserved population; (2) determine if this TMS treatment protocol improves PTSD symptoms and biological markers of PTSD such as brain functioning and startle responses; (3) define new brain targets for future TMS studies; (4) provide the first data for individual differences, which will help personalize treatment for PTSD patients; (5) improve knowledge of the neurobiology of PTSD and treatment response.
Interventions
- DEVICE Transcranial Magnetic Stimulation (TMS)
- PROCEDURE Sham Transcranial Magnetic Stimulation (TMS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-02-15 |
| Est. Completion | 2025-09-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04563078
The ClinicalTrials.gov registry entry for NCT04563078 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT04563078 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04563078 about?
NCT04563078 is a clinical study titled "Effect of TMS on PTSD Biomarkers". The study will (1) assess feasibility of a TMS treatment in an underserved population; (2) determine if this TMS treatment protocol improves PTSD symptoms and biological markers of PTSD such as brain functioning and startle responses; (3) define new brain targets for future TMS studies; (4) provide ...
What is the current status of trial NCT04563078?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-02-15. Estimated completion is 2025-09-28.
What interventions are being tested in trial NCT04563078?
The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE), Sham Transcranial Magnetic Stimulation (TMS) (PROCEDURE).
Who is sponsoring clinical trial NCT04563078?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.